Filing metadata

Accession number
0001562180-24-000784
Form type
Form 4
Filer
EyePoint Pharmaceuticals, Inc.
CIK
CIK 1314102
Filed
Jan 29, 2024
Reporting period
Jan 25, 2024
Description
Insider transaction

Explore SEC Filings Hub